PLRX
NASDAQ · Pharmaceuticals
Pliant Therapeutics Inc
$1.32
+0.04 (+3.13%)
Open$1.31
Previous Close$1.28
Day High$1.34
Day Low$1.30
52W High$1.95
52W Low$1.09
Volume—
Avg Volume612.7K
Market Cap82.35M
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Sell
12 analysts
Price Target
+1,193.9% upside
Current
$1.32
$1.32
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.16M | 13.79M | 14.54M |
| Net Income | 3.08M | 2.65M | 3.08M |
| Profit Margin | 20.3% | 19.2% | 21.2% |
| EBITDA | 5.59M | 4.59M | 4.96M |
| Free Cash Flow | 2.06M | 2.45M | 2.36M |
| Rev Growth | +19.0% | -9.0% | -2.1% |
| Debt/Equity | 0.34 | 0.31 | 0.34 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |